N/A
Ciaffi, J., Ursini, F. (2026). Commentary on: “Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial”. ARTHRITIS & RHEUMATOLOGY, N/A, 1-4 [10.1002/art.70212].
Commentary on: “Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial”
Ciaffi, Jacopo
Primo
;Ursini, FrancescoUltimo
2026
Abstract
N/AFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Arthritis Rheumatology - 2026 - Ciaffi - Commentary on Ixekizumab With Tirzepatide Achieved Greater Disease Control (1).pdf
embargo fino al 07/05/2027
Tipo:
Postprint / Author's Accepted Manuscript (AAM) - versione accettata per la pubblicazione dopo la peer-review
Licenza:
Licenza per accesso libero gratuito
Dimensione
228.93 kB
Formato
Adobe PDF
|
228.93 kB | Adobe PDF | Visualizza/Apri Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
